Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ. (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol (Nov), 7(11): 1646-1654.
Murray JL, Rosenblum MG, Zhang HZ, Podoloff DA, Kasi LP, Curley SA, Chan JC, Roh M, Hohn DC, Brewer H. (1994) Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients. Cancer (Feb), 73(3 Sup): 850-857.
Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. (1994) Complications and failures of subclavian-vein catheterization. N Engl J Med (Dec), 331(26): 1735-1738.
Berger DH, Carrasco CH, Hohn DC, Curley SA. (1995) Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol (Oct), 60(2): 116-121.
Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, Edge SB. (2001) Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition. Am J Clin Oncol (Aug), 24(4): 425-428.
Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. (1994) Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol (Apr), 15(4 Pt): 231-238.
Bold RJ, Mansfield PF, Berger DH, Pollock RE, Singletary SE, Ames FC, Balch CM, Hohn DC, Ross MI. (1998) Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. Am J Surg (Sep), 176(3): 239-243.
Jones DV, Chase J, Roh M, Hohn DC, Curley S, Smith R, and Patt YZ. (1900) A phase I evaluation of chronotropic delivery of floxuridine by hepatic arterial infusion in patients with metastatic colorectal cancer. (Jan) 391-395
Hohn DC, Stagg RJ, Friedman MA, Hannigan JR Jr, Rayner A, Ignoffo RJ, Acord P, and Lewis BJ. (1900) A randomized trial of continious intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. (Jan) 458-466
Rosenblum MG, Levin B, Roh M, Hohn DC, McCabe R, Thompson L, Cheung L and Murray JL. (1900) Clinical pharmacology and tissue disposition studies of 131I labeled anticolorectal carcinoma human monoclonal antibody LiCO 16.88. (Jan) 397-400
Curley SA, Newman RA, Dougherty TB, Fuhrman GM, Stone DL, Mikolajek JA, Guercio S, Guercio A, Carrasco CH, Kuo MT, and Hohn DC. (1900) Complete hepatic venous isolation extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study. (Jan) 389-399
Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, and Ota DM. (1900) Complications and failures of subclavian vein catheterization. (Jan) 1735-1738
Abi-Said D., Raad I., Umphrey J., Gonzalez V., Richardson D., Marts K., Hohn D. (1999) Infusion therapy team and dressing changes of central venous catheters [see comments]. (Feb) 101-105
Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield P F, and Bodey GP. (1900) Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. (Jan) 238
Rubenstein EB, Fender A, Rolston KVI, Elting LS, Prasco P, Palmer J, Raad I, Pollock RE, Frisbee-Hume S, Laurence D, and Hohn DC. (1900) Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. (Jan) 1513-1519
In the Media:
Roswell Park Cancer Institute Elm & Carlton Streets Buffalo, New York 14263 Phone: (716) 845-5772 email@example.com